Pfizer asks FDA to allow COVID-19 vaccine for kids under 5
WASHINGTON Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving
FDA advisers back Pfizer’s COVID-19 vaccine for young kids
WASHINGTON A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer s COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11.
US clears Moderna vaccine for COVID-19, 2nd shot in arsenal
WASHINGTON The U.S. added a second COVID-19 vaccine to its arsenal Friday, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day.
Will the US ever have a national COVID-19 testing strategy?
NEW YORK As the coronavirus epidemic worsens, U.S. health experts hope Joe Biden s administration will put in place something Donald Trump s has not a comprehensive national testing strategy.
Government virus testing will prioritize medical staff, elderly
WASHINGTON The federal government s effort to rapidly expand testing for the coronavirus will initially focus on screening health care workers and the elderly, Trump administration officials said Su
Virus testing is a ‘failing,’ leaving cases uncounted
NEW YORK Seven weeks have passed since the first U.S. case of coronavirus was announced, and the government is failing to account for what could be thousands of additional infections because of ongo